AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 20 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,571,000 | -21.4% | 7,700,000 | -16.6% | 0.12% | -13.4% |
| Q1 2022 | $8,358,000 | +12.4% | 9,235,000 | +4.1% | 0.13% | +7.2% |
| Q4 2021 | $7,437,000 | -15.9% | 8,869,000 | -8.3% | 0.12% | -23.8% |
| Q3 2021 | $8,842,000 | -6.9% | 9,667,000 | +1.5% | 0.16% | -11.4% |
| Q2 2021 | $9,499,000 | +40.2% | 9,525,000 | +45.4% | 0.18% | +26.7% |
| Q1 2021 | $6,774,000 | – | 6,550,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |